Jane Street’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Jane Street’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-52,173	Closed	-$973K	–	11482
2022 Q1	$973K	Buy	+52,173	New	+$939K	﹤0.01%	6201
2021 Q4	–	Sell	-72,759	Closed	-$1.34M	–	11121
2021 Q3	$1.34M	Buy	72,759 +35,040	+93%	+$706K	﹤0.01%	5304
2021 Q2	$808K	Buy	+37,719	New	+$767K	﹤0.01%	6302

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Jane Street's OCDX Position: Q2 2022 in Review

Jane Street sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 52,173 shares — an estimated $973K sold.

Jane Street first reported a position in OCDX in Q2 2021 and held it in 3 quarters. The position peaked at $1.34M in Q3 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Jane Street reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Jane Street sold 52,173 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $973K.
Jane Street first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
Jane Street's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.34M in Q3 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Jane Street's 13F filing for Q2 2022, filed 16 Aug 2022.